De Novo closes $250m life science fund
The Menlo Park, California venture capital firm’s second fund will focus on seed and early stage medical technology and biotechnology opportunities.
The Menlo Park, California venture capital firm’s second fund will focus on seed and early stage medical technology and biotechnology opportunities.
Copyright PEI Media
Not for publication, email or dissemination